Synthesis and Application of Injectable Bioorthogonal Dendrimer Hydrogels for Local Drug Delivery.

Synthesis and Application of Injectable Bioorthogonal Dendrimer Hydrogels for Local Drug Delivery.
复制标题

DOI:
10.1021/acsbiomaterials.7b00166
复制
发表时间:
2017-08-14
影响因子:
5.8
通讯作者:
Yang H
Yang H
中科院分区:
工程技术2区
文献类型:
--
作者:
Xu L;Cooper RC;Wang J;Yeudall WA;Yang H

文献摘要

参考文献

被引文献

相似文献

采用生物正交化学方法,将聚酰胺-胺(PAMAM)树枝状大分子4.0代(G4)通过聚乙二醇(PEG)间隔基与应变炔二苯并环辛炔(DBCO)功能化,制备了新型树枝状大分子水凝胶(DH(Mn = 2,000 g/mol)与聚乙二醇双叠氮化物(PEG-BA)进行应变促进的叠氮化物-炔环加成(SPAAC)(Mn= 20,000 g/mol)以产生树枝状聚合物-PEG交联网络。该平台提供了高度的功能性和模块化。可以容易地操纵宽范围的结构参数,包括树枝状聚合物生成、PEG化程度、可点击DBCO基团的负载密度、PEG-BA链长以及可点击树枝状聚合物与PEG-BA的比率及其浓度,以调节DH的化学和物理性质。我们使用这个平台来制备可注射液体DH。这种生物正交DH具有高细胞相容性,并使抗癌药物5-氟尿嘧啶(5-FU)的持续释放。瘤内注射后,DH/5-FU制剂通过促进肿瘤细胞死亡以及通过减少肿瘤细胞增殖和血管生成显著抑制肿瘤生长并改善荷HN 12肿瘤小鼠的存活率。
We developed novel dendrimer hydrogels (DH)s on the basis of bioorthogonal chemistry, in which polyamidoamine (PAMAM) dendrimer generation 4.0 (G4) functionalized with strained alkyne dibenzocyclooctyne (DBCO) via PEG spacer (Mn = 2,000 g/mol) underwent strain-promoted azide-alkyne cycloaddition (SPAAC) with polyethylene glycol bisazide (PEG-BA) (Mn= 20,000 g/mol) to generate a dendrimer-PEG cross-linked network. This platform offers a high degree of functionality and modularity. A wide range of structural parameters including dendrimer generation, degree of PEGylation, loading density of clickable DBCO groups, PEG-BA chain length as well as the ratio of clickable dendrimer to PEG-BA and their concentrations can be readily manipulated to tune chemical and physical properties of DHs. We used this platform to prepare an injectable liquid DH. This bioorthogonal DH exhibited high cytocompatibility and enabled sustained release of the anticancer drug 5-fluorouracil (5-FU). Following intratumoral injection, the DH/5-FU formulation significantly suppressed tumor growth and improved survival of HN12 tumor-bearing mice by promoting tumor cell death as well as by reducing tumor cell proliferation and angiogenesis.
DOI: 10.1016/j.ijpharm.2016.03.061
发表时间: 2016-05-30
影响因子: 5.8
作者:
Buczkowski, Adam;Waliszewski, Dariusz;Palecz, Bartlomiej
通讯作者: Palecz, Bartlomiej
DOI: 10.1016/j.ijbiomac.2006.04.010
发表时间: 2006-11-15
影响因子: 8.2
作者:
Nickerson, M. T.;Patel, J.;Paulson, A. T.
通讯作者: Paulson, A. T.
DOI: 10.1016/j.canlet.2008.03.008
发表时间: 2008-08-18
期刊: CANCER LETTERS
影响因子: 9.7
作者:
Ooyama, Akio;Oka, Toshinori;Fukushima, Masakazu
通讯作者: Fukushima, Masakazu
DOI: 10.1016/j.biomaterials.2015.11.064
发表时间: 2016-02
期刊: Biomaterials
影响因子: 14
作者:
Mukerji R;Schaal J;Li X;Bhattacharyya J;Asai D;Zalutsky MR;Chilkoti A;Liu W
通讯作者: Liu W
DOI: 10.1016/j.nano.2011.08.018
发表时间: 2012-07-01
影响因子: 5.4
作者:
Holden, Christopher A.;Tyagi, Puneet;Yang, Hu
通讯作者: Yang, Hu